QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC

Clinical trial NCT06786026 · RECRUITING

Trial details

NCT number: NCT06786026
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

TNBC, Triple Negative Breast Cancer

Start date: 2024-10-09
Primary completion: 2025-09-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.